Digitally created image of a double helix

Genetic Repositories Australia (GRA)

FACILITY INFORMATION

In accordance with NHMRC Enabling Grant requirements GRA has established 3 committees:

  • Management Committee
  • Scientific Advisory Committee
  • Independent Appeals Committee

The Management Committee (MC) operates under defined terms of reference and provides management and oversight of the day-to-day management of the GRA facility. The MC role is to ensure that appropriate ethical standards are met, ensuring open access to all researchers, and overseeing the resolution of any disputes consistent with NHMRC Enabling Facility Access Policy.

  • The GRA MC comprises the four Chief Investigators and the Facility Manager.
  • Professor Peter Schofield BScAgr, PhD, DSc
  • Executive Director & CEO, Neuroscience Research Australia
  • Assoc Prof Juleen Cavanaugh BSc, MS, PhD
  • Senior Lecturer, Australian National University
  • Dr Susan Forrest BSc (Hons), D Phil, BA Business
  • Director, Australian Genome Research Facility Ltd
  • Professor John Hopper BA, MSc, PhD
  • NHMRC Senior Principal Research Fellow, The University of Melbourne
  • Steve Turner BAppSc, BSc (Hons), MSc, Grad Cert Man
  • Facility Manager, Genetic Repositories Australia.

A Scientific Advisory Committee (SAC) which consists of nine members. The SAC membership reflects a skills-based committee, with an appropriate mix of expertise to allow the SAC to provide advice in all areas of operations of the GRA facility. GRA’s SAC provides strategic advice and reviews progress towards establishing and operating GRA as an NHMRC Enabling Facility, including advice on governance, management and operations. The SAC is comprised of a majority of external appointments & includes all members from the GRA MC and the Facility Manager (Ex Officio).

External SAC members are listed below:

  • Professor Graham MacDonald, Formerly External Licensing Coordinator, Merck Sharp & Dohme (Australia)
  • Professor Don Chalmers, Faculty of Law, University of Tasmania
  • Theo Magoulas, Assistant University Solicitor, University of Technology Legal Services
  • Professor Phil Mitchell, Head School of Psychiatry, University of NSW
  • Dr Bruce Ross, Health Solutions Executive, Health Solutions Group Microsoft Australia.

An Independent Appeals Committee (IAC) of ’eminent persons’ who are independent of GRA and represent a range of consumer, scientific and social scientific disciplines. The IAC has been established to resolve any dispute concerning access to or operations of the facility and comprises individuals outside both Management and the SAC. The IAC comprises the following members:

  • Professor Ron Trent, Professor of Medicine at University of Sydney and Royal Prince Alfred Hospital
  • Peter Kemp, Founder of Kemp Strang Lawyers
  • A Consumer or Community Representative, (Position currently vacant)
See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

Brain and Knee Muscle Weakness Study

Why Does Quadriceps Weakness Persist after Total Knee Replacement? An Exploration of Neurophysiological Mechanisms Total knee replacement is a commonly performed surgery for treating end-staged knee osteoarthritis. Although most people recover well after surgery, weakness of the quadriceps muscles (the front thigh muscles) persists long after the surgery (at least for 12 months), despite intensive physiotherapy and exercise. Quadriceps muscle weakness is known to be associated with more severe pain and greatly affect daily activities. This study aims to investigate the mechanisms underlying weakness of the quadriceps muscles in people with knee osteoarthritis and total knee replacement. We hope to better understand the relationship between the changes of the brain and a loss of quadriceps muscle strength after total knee replacement. The study might be a good fit for you if you: Scheduled to undergo a total knee replacement; The surgery is scheduled within the next 4 weeks; Do not have a previous knee joint replacement in the same knee; Do not have high tibial osteotomy; Do not have neurological disorders, epilepsy, psychiatric conditions, other chronic pain conditions; Do not have metal implants in the skull; Do not have a loss of sensation in the limbs. If you decide to take part you would: Be contacted by the researcher to determine your eligibility for the study Be scheduled for testing if you are eligible and willing to take part in the study Sign the Consent Form when you attend the first testing session Attend 3 testing sessions (approximately 2 hours per session): 1) before total knee replacement, 2) 3 months and 3) 6 months after total knee replacement. The testing will include several non-invasive measures of brain representations of the quadriceps muscles, central pain mechanisms, and motor function and questionnaires. Will I be paid to take part in the research study? You will be reimbursed ($50.00 per session) for travel and parking expenses associated with the research study visits. If you would like more information or are interested in being part of the study, please contact: Name: Dr Wei-Ju Chang Email: w.chang@neura.edu.au Phone: 02 9399 1260 This research is being funded by the Physiotherapy Research Foundation.  
PROJECT